 | • レポートコード：20QY06-06917 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、静脈内ソリューションのグローバル市場について種類別（クリスタロイド、コロイド、その他）、用途別（ベーシックIVソリューション、栄養注入ソリューション、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・静脈内ソリューション市場の概要 ・世界の主要地域別静脈内ソリューション市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の静脈内ソリューション市場規模2015-2026：種類別（クリスタロイド、コロイド、その他） ・世界の静脈内ソリューション市場規模2015-2026：用途別（ベーシックIVソリューション、栄養注入ソリューション、その他） ・静脈内ソリューションの北米市場規模2015-2020 ・静脈内ソリューションのヨーロッパ市場規模2015-2020 ・静脈内ソリューションの中国市場規模2015-2020 ・静脈内ソリューションの日本市場規模2015-2020 ・静脈内ソリューションの東南アジア市場規模2015-2020 ・静脈内ソリューションのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Baxter、Kelun Group、Fresenius Kabi、Otsuka、ICU Medical、Fresenius Kabi、JW Life Science、B. Braun Melsungen） ・静脈内ソリューションの製造コスト分析 ・販売チャネル、流通業者、顧客 ・静脈内ソリューションの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Intravenous Solutions Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Intravenous Solutions market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous Solutions market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Intravenous Solutions industry.
Based on our recent survey, we have several different scenarios about the Intravenous Solutions YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 9681.7 million in 2019. The market size of Intravenous Solutions will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Intravenous Solutions market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Intravenous Solutions market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Intravenous Solutions market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Intravenous Solutions market. The report also includes nautical information, where it shows Intravenous Solutions market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Intravenous Solutions market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Intravenous Solutions market.
Leading players in the industry are Baxter, Kelun Group and Fresenius Kabi, which accounted for 20.99%, 16.71% and 11.53% of revenues in 2019. By region, the Asia-Pacific region has the highest share of income, reaching 41.48 percent in 2019.
Geographical Analysis:
Based on region, the global Intravenous Solutions market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Intravenous Solutions market are
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
Fresenius Kabi
JW Life Science
B. Braun Melsungen
Segment by Type
Crystalloids
Colloids
Others
Crystalloids has the highest share of revenue by type, more than 76% in 2019.
Segment by Application
Basic IV Solutions
Nutrient Infusion Solution
Others
Basic IV solutions has the highest percentage of sales by application, reaching 65.98% in 2019.
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Intravenous Solutions market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Intravenous Solutions market.
• The market share of the global Intravenous Solutions market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Intravenous Solutions market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Intravenous Solutions market.
1 Intravenous Solutions Market Overview
1.1 Intravenous Solutions Product Scope
1.2 Intravenous Solutions Segment by Type
1.2.1 Global Intravenous Solutions Sales by Type (2020-2026)
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Intravenous Solutions Segment by Application
1.3.1 Global Intravenous Solutions Sales Comparison by Application (2020-2026)
1.3.2 Basic IV Solutions
1.3.3 Nutrient Infusion Solution
1.3.4 Others
1.4 Intravenous Solutions Market Estimates and Forecasts (2015-2026)
1.4.1 Global Intravenous Solutions Sales Growth Rate (2015-2026)
1.4.2 Global Intravenous Solutions Revenue and Growth Rate (2015-2026)
1.4.3 Global Intravenous Solutions Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Intravenous Solutions Industry Impact
1.5.1 How the Covid-19 is Affecting the Intravenous Solutions Industry
1.5.1.1 Intravenous Solutions Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Intravenous Solutions Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Intravenous Solutions Players to Combat Covid-19 Impact
2 Intravenous Solutions Estimate and Forecast by Region
2.1 Global Intravenous Solutions Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Intravenous Solutions Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Intravenous Solutions Sales Market Share by Region (2015-2020)
2.2.2 Global Intravenous Solutions Revenue Market Share by Region (2015-2020)
2.3 Global Intravenous Solutions Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Intravenous Solutions Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Intravenous Solutions Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Intravenous Solutions Estimates and Projections (2015-2026)
2.4.2 Europe Intravenous Solutions Estimates and Projections (2015-2026)
2.4.3 China Intravenous Solutions Estimates and Projections (2015-2026)
2.4.4 Japan Intravenous Solutions Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Intravenous Solutions Estimates and Projections (2015-2026)
2.4.6 India Intravenous Solutions Estimates and Projections (2015-2026)
3 Global Intravenous Solutions Competition Landscape by Players
3.1 Global Top Intravenous Solutions Players by Sales (2015-2020)
3.2 Global Top Intravenous Solutions Players by Revenue (2015-2020)
3.3 Global Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions as of 2019)
3.4 Global Intravenous Solutions Average Price by Company (2015-2020)
3.5 Manufacturers Intravenous Solutions Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Intravenous Solutions Players (Opinion Leaders)
4 Global Intravenous Solutions Market Size by Type
4.1 Global Intravenous Solutions Historic Market Review by Type (2015-2020)
4.1.1 Global Intravenous Solutions Sales Market Share by Type (2015-2020)
4.1.2 Global Intravenous Solutions Revenue Market Share by Type (2015-2020)
4.1.3 Global Intravenous Solutions Price by Type (2014-2020)
4.2 Global Intravenous Solutions Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Intravenous Solutions Sales Forecast by Type (2021-2026)
4.2.2 Global Intravenous Solutions Revenue Forecast by Type (2021-2026)
4.2.3 Global Intravenous Solutions Price Forecast by Type (2021-2026)
5 Global Intravenous Solutions Market Size by Application
5.1 Global Intravenous Solutions Historic Market Review by Application (2015-2020)
5.1.1 Global Intravenous Solutions Sales Market Share by Application (2015-2020)
5.1.2 Global Intravenous Solutions Revenue Market Share by Application (2015-2020)
5.1.3 Global Intravenous Solutions Price by Application (2015-2020)
5.2 Global Intravenous Solutions Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Intravenous Solutions Sales Forecast by Application (2021-2026)
5.2.2 Global Intravenous Solutions Revenue Forecast by Application (2021-2026)
5.2.3 Global Intravenous Solutions Price Forecast by Application (2021-2026)
3 North America Intravenous Solutions Market Facts & Figures
3.2 North America Intravenous Solutions Sales Market Share by Company (2015-2020)
3.3 North America Intravenous Solutions Sales Market Share by Type (2015-2020)
3.4 North America Intravenous Solutions Sales Market Share by Application (2015-2020)
4 Europe Intravenous Solutions Market Facts & Figures
4.2 Europe Intravenous Solutions Sales Market Share by Company (2015-2020)
4.3 Europe Intravenous Solutions Sales Market Share by Type (2015-2020)
4.4 Europe Intravenous Solutions Sales Market Share by Application (2015-2020)
5 China Intravenous Solutions Market Facts & Figures
5.2 China Intravenous Solutions Sales Market Share by Company (2015-2020)
5.3 China Intravenous Solutions Sales Market Share by Type (2015-2020)
5.4 China Intravenous Solutions Sales Market Share by Application (2015-2020)
6 Japan Intravenous Solutions Market Facts & Figures
6.2 Japan Intravenous Solutions Sales Market Share by Company (2015-2020)
6.3 Japan Intravenous Solutions Sales Market Share by Type (2015-2020)
6.4 Japan Intravenous Solutions Sales Market Share by Application (2015-2020)
7 Southeast Asia Intravenous Solutions Market Facts & Figures
7.2 Southeast Asia Intravenous Solutions Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Intravenous Solutions Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Intravenous Solutions Sales Market Share by Application (2015-2020)
8 India Intravenous Solutions Market Facts & Figures
8.2 India Intravenous Solutions Sales Market Share by Company (2015-2020)
8.3 India Intravenous Solutions Sales Market Share by Type (2015-2020)
8.4 India Intravenous Solutions Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Intravenous Solutions Business
12.1 Baxter
12.1.1 Baxter Intravenous Solutions Corporation Information
12.1.2 Baxter Intravenous Solutions Business Overview and Total Revenue
12.1.3 Baxter Intravenous Solutions Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Baxter Intravenous Solutions Products Offered
12.1.5 Baxter Recent Development
12.2 Kelun Group
12.2.1 Kelun Group Intravenous Solutions Corporation Information
12.2.2 Kelun Group Intravenous Solutions Business Overview and Total Revenue
12.2.3 Kelun Group Intravenous Solutions Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Kelun Group Intravenous Solutions Products Offered
12.2.5 Kelun Group Recent Development
12.3 Fresenius Kabi
12.3.1 Fresenius Kabi Intravenous Solutions Corporation Information
12.3.2 Fresenius Kabi Intravenous Solutions Business Overview and Total Revenue
12.3.3 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Fresenius Kabi Intravenous Solutions Products Offered
12.3.5 Fresenius Kabi Recent Development
12.4 Otsuka
12.4.1 Otsuka Intravenous Solutions Corporation Information
12.4.2 Otsuka Intravenous Solutions Business Overview and Total Revenue
12.4.3 Otsuka Intravenous Solutions Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Otsuka Intravenous Solutions Products Offered
12.4.5 Otsuka Recent Development
12.5 ICU Medical
12.5.1 ICU Medical Intravenous Solutions Corporation Information
12.5.2 ICU Medical Intravenous Solutions Business Overview and Total Revenue
12.5.3 ICU Medical Intravenous Solutions Sales, Revenue and Gross Margin (2015-2020)
12.5.4 ICU Medical Intravenous Solutions Products Offered
12.5.5 ICU Medical Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Intravenous Solutions Corporation Information
12.6.2 Fresenius Kabi Intravenous Solutions Business Overview and Total Revenue
12.6.3 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Fresenius Kabi Intravenous Solutions Products Offered
12.6.5 Fresenius Kabi Recent Development
12.7 JW Life Science
12.7.1 JW Life Science Intravenous Solutions Corporation Information
12.7.2 JW Life Science Intravenous Solutions Business Overview and Total Revenue
12.7.3 JW Life Science Intravenous Solutions Sales, Revenue and Gross Margin (2015-2020)
12.7.4 JW Life Science Intravenous Solutions Products Offered
12.7.5 JW Life Science Recent Development
12.8 B. Braun Melsungen
12.8.1 B. Braun Melsungen Intravenous Solutions Corporation Information
12.8.2 B. Braun Melsungen Intravenous Solutions Business Overview and Total Revenue
12.8.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue and Gross Margin (2015-2020)
12.8.4 B. Braun Melsungen Intravenous Solutions Products Offered
12.8.5 B. Braun Melsungen Recent Development
13 Intravenous Solutions Manufacturing Cost Analysis
13.1 Intravenous Solutions Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Intravenous Solutions
13.4 Intravenous Solutions Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Intravenous Solutions Distributors List
14.3 Intravenous Solutions Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Intravenous Solutions Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Intravenous Solutions Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Intravenous Solutions Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Intravenous Solutions Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Intravenous Solutions Players to Combat Covid-19 Impact
Table 8. Global Market Intravenous Solutions Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Intravenous Solutions Sales (M Units) by Region (2015-2020)
Table 10. Global Intravenous Solutions Sales Market Share by Region (2015-2020)
Table 11. Global Intravenous Solutions Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Intravenous Solutions Revenue Share by Region (2015-2020)
Table 13. Global Intravenous Solutions Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Intravenous Solutions Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Intravenous Solutions Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Intravenous Solutions Revenue Share Forecast by Region (2021-2026)
Table 17. Global Intravenous Solutions (M Units) of Key Companies (2015-2020)
Table 18. Global Intravenous Solutions Sales Share by Company (2015-2020)
Table 19. Global Intravenous Solutions Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Intravenous Solutions Revenue Share by Company (2015-2020)
Table 21. Global Intravenous Solutions by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions as of 2019)
Table 22. Global Intravenous Solutions Average Price (US$/K Unit) of Key Company (2015-2020)
Table 23. Manufacturers Intravenous Solutions Manufacturing Sites and Area Served
Table 24. Manufacturers Intravenous Solutions Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Intravenous Solutions Players
Table 27. Global Intravenous Solutions Sales (M Units) by Type (2015-2020)
Table 28. Global Intravenous Solutions Sales Share by Type (2015-2020)
Table 29. Global Intravenous Solutions Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Intravenous Solutions Price (M Units) by Type (2015-2020)
Table 31. Global Intravenous Solutions Sales Share by Type (2021-2026)
Table 32. Global Intravenous Solutions Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Intravenous Solutions Revenue Share by Type (2021-2026)
Table 34. Global Intravenous Solutions Price (M Units) by Type (2021-2026)
Table 35. Global Intravenous Solutions Sales (M Units) by Application (2015-2020)
Table 36. Global Intravenous Solutions Sales Share by Application (2015-2020)
Table 37. Global Intravenous Solutions Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Intravenous Solutions Price (M Units) by Application (2015-2020)
Table 39. Global Intravenous Solutions Sales (M Units) by Application (2021-2026)
Table 40. Global Intravenous Solutions Sales Share by Application (2021-2026)
Table 41. Global Intravenous Solutions Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Intravenous Solutions Revenue Share by Application (2021-2026)
Table 43. Global Intravenous Solutions Price (M Units) by Application (2021-2026)
Table 44. United States Intravenous Solutions Sales (M Units) by Company (2015-2020)
Table 45. United States Intravenous Solutions Sales Market Share by Company (2015-2020)
Table 46. United States Intravenous Solutions Sales (M Units) by Type (2015-2020)
Table 47. United States Intravenous Solutions Sales Market Share by Type (2015-2020)
Table 48. United States Intravenous Solutions Sales (M Units) by Application (2015-2020)
Table 49. United States Intravenous Solutions Sales Market Share by Application (2015-2020)
Table 50. Europe Intravenous Solutions Sales (M Units) by Company (2015-2020)
Table 51. Europe Intravenous Solutions Sales Market Share by Company (2015-2020)
Table 52. Europe Intravenous Solutions Sales (M Units) by Type (2015-2020)
Table 53. Europe Intravenous Solutions Sales Market Share by Type (2015-2020)
Table 54. Europe Intravenous Solutions Sales (M Units) by Application (2015-2020)
Table 55. Europe Intravenous Solutions Sales Market Share by Type (2015-2020)
Table 56. China Intravenous Solutions Sales (M Units) by Company (2015-2020)
Table 57. China Intravenous Solutions Sales Market Share by Company (2015-2020)
Table 58. China Intravenous Solutions Sales (M Units) by Type (2015-2020)
Table 59. China Intravenous Solutions Sales Market Share by Type (2015-2020)
Table 60. China Intravenous Solutions Sales (M Units) by Application (2015-2020)
Table 61. China Intravenous Solutions Sales Market Share by Application (2015-2020)
Table 62. Japan Intravenous Solutions Sales (M Units) by Company (2015-2020)
Table 63. Japan Intravenous Solutions Sales Market Share by Company (2015-2020)
Table 64. Japan Intravenous Solutions Sales (M Units) by Type (2015-2020)
Table 65. Japan Intravenous Solutions Sales Market Share by Type (2015-2020)
Table 66. Japan Intravenous Solutions Sales (M Units) by Application (2015-2020)
Table 67. Japan Intravenous Solutions Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Intravenous Solutions Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Intravenous Solutions Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Intravenous Solutions Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Intravenous Solutions Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Intravenous Solutions Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Intravenous Solutions Sales Market Share by Application (2015-2020)
Table 74. India Intravenous Solutions Sales (M Units) by Company (2015-2020)
Table 75. India Intravenous Solutions Sales Market Share by Company (2015-2020)
Table 76. India Intravenous Solutions Sales (M Units) by Type (2015-2020)
Table 77. India Intravenous Solutions Sales Market Share by Type (2015-2020)
Table 78. India Intravenous Solutions Sales (M Units) by Application (2015-2020)
Table 79. India Intravenous Solutions Sales Market Share by Application (2015-2020)
Table 80. Baxter Corporation Information
Table 81. Baxter Description and Business Overview
Table 82. Baxter Intravenous Solutions Sales (M Units), Revenue (Million USD), Price (US$/K Unit) and Gross Margin (2015-2020)
Table 83. Baxter Intravenous Solutions Product
Table 84. Baxter Recent Development
Table 85. Kelun Group Corporation Information
Table 86. Kelun Group Description and Business Overview
Table 87. Kelun Group Intravenous Solutions Sales (M Units), Revenue (Million USD), Price (US$/K Unit) and Gross Margin (2015-2020)
Table 88. Kelun Group Intravenous Solutions Product
Table 89. Kelun Group Recent Development
Table 90. Fresenius Kabi Corporation Information
Table 91. Fresenius Kabi Description and Business Overview
Table 92. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (Million USD), Price (US$/K Unit) and Gross Margin (2015-2020)
Table 93. Fresenius Kabi Intravenous Solutions Product
Table 94. Fresenius Kabi Recent Development
Table 95. Otsuka Corporation Information
Table 96. Otsuka Description and Business Overview
Table 97. Otsuka Intravenous Solutions Sales (M Units), Revenue (Million USD), Price (US$/K Unit) and Gross Margin (2015-2020)
Table 98. Otsuka Intravenous Solutions Product
Table 99. Otsuka Recent Development
Table 100. ICU Medical Corporation Information
Table 101. ICU Medical Description and Business Overview
Table 102. ICU Medical Intravenous Solutions Sales (M Units), Revenue (Million USD), Price (US$/K Unit) and Gross Margin (2015-2020)
Table 103. ICU Medical Intravenous Solutions Product
Table 104. ICU Medical Recent Development
Table 105. Fresenius Kabi Corporation Information
Table 106. Fresenius Kabi Description and Business Overview
Table 107. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (Million USD), Price (US$/K Unit) and Gross Margin (2015-2020)
Table 108. Fresenius Kabi Intravenous Solutions Product
Table 109. Fresenius Kabi Recent Development
Table 110. JW Life Science Corporation Information
Table 111. JW Life Science Description and Business Overview
Table 112. JW Life Science Intravenous Solutions Sales (M Units), Revenue (Million USD), Price (US$/K Unit) and Gross Margin (2015-2020)
Table 113. JW Life Science Intravenous Solutions Product
Table 114. JW Life Science Recent Development
Table . B. Braun Melsungen Corporation Information
Table . B. Braun Melsungen Intravenous Solutions Sales (M Units), Revenue (Million USD), Price (US$/K Unit) and Gross Margin (2015-2020)
Table . B. Braun Melsungen Description and Business Overview
Table . B. Braun Melsungen Intravenous Solutions Product
Table . B. Braun Melsungen Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Intravenous Solutions Distributors List
Table 123. Intravenous Solutions Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Solutions Product Picture
Figure 2. Global Intravenous Solutions Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Intravenous Solutions Market Share by Application in 2020 & 2026
Figure 6. Basic IV Solutions Examples
Figure 7. Nutrient Infusion Solution Examples
Figure 8. Others Examples
Figure 9. Global Intravenous Solutions Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Intravenous Solutions Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Intravenous Solutions Price Trends Growth Rate (2015-2026) (US$/K Unit)
Figure 12. Global Intravenous Solutions Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Intravenous Solutions Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Intravenous Solutions Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Intravenous Solutions Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Intravenous Solutions Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Intravenous Solutions Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Intravenous Solutions Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Intravenous Solutions Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Intravenous Solutions Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Intravenous Solutions Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Intravenous Solutions Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Intravenous Solutions Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Intravenous Solutions Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Intravenous Solutions Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Intravenous Solutions Players Market Share by Revenue in Intravenous Solutions 2015 & 2019
Figure 27. Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Intravenous Solutions Revenue Share by Type (2015-2020)
Figure 29. Global Intravenous Solutions Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Intravenous Solutions Revenue Share by Application (2015-2020)
Figure 31. Global Intravenous Solutions Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Intravenous Solutions Sales Market Share by Type in 2019
Figure 33. United States Intravenous Solutions Sales Market Share by Type in 2019
Figure 34. Europe Intravenous Solutions Sales Market Share by Company in 2019
Figure 35. Europe Intravenous Solutions Sales Market Share by Type in 2019
Figure 36. Europe Intravenous Solutions Sales Market Share by Application in 2019
Figure 37. China Intravenous Solutions Sales Market Share by Company in 2019
Figure 38. China Intravenous Solutions Sales Market Share by Type in 2019
Figure 39. China Intravenous Solutions Sales Market Share by Application in 2019
Figure 40. Japan Intravenous Solutions Sales Market Share by Company in 2019
Figure 41. Japan Intravenous Solutions Sales Market Share by Type in 2019
Figure 42. Japan Intravenous Solutions Sales Market Share by Application in 2019
Figure 43. Southeast Asia Intravenous Solutions Sales Market Share by Company in 2019
Figure 44. Southeast Asia Intravenous Solutions Sales Market Share by Type in 2019
Figure 45. Southeast Asia Intravenous Solutions Sales Market Share by Application in 2019
Figure 46. India Intravenous Solutions Sales Market Share by Company in 2019
Figure 47. India Intravenous Solutions Sales Market Share by Type in 2019
Figure 48. India Intravenous Solutions Sales Market Share by Application in 2019
Figure 49. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Kelun Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. ICU Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. JW Life Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. B. Braun Melsungen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Intravenous Solutions
Figure 59. Manufacturing Process Analysis of Intravenous Solutions
Figure 60. Intravenous Solutions Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
ソリリス静脈内の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Soliris Intravenous market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Soliris Intravenous marke…- 静脈内注入ポンプの世界市場レポート2020 Intravenous infusion pump is a medical device used to infuse medications or nutrients into a patients circulatory system. These are commonly found in a medical setting as they are widely used in transferring medications in accurate dosages. Key factors that drive the market are increase in geriatric…
- 静脈フィルターの世界市場レポート2020 Market Analysis and Insights: Global Intravenous Filter Market The global Intravenous Filter market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Intravenous Filter Scope and Market Size The global Intravenous…
- 静脈内輸液バッグの世界市場レポート2020 Intravenous solutions contain amino acids, dextrose, mineral salts, vitamins, and trace elements, and therefore cover the basic essential components (carbohydrates, proteins, fats, water, electrolytes, vitamins, and minerals) required to build tissue, for energy expenditure, and other physiological …
- 静脈内免疫グロブリン（IVIg）の世界市場レポート2020 Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin. North America regi…